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Vascular changes in the cerebellum of Norrin /Ndph knockout
mice correlate with high expression of Norrin and Frizzled-4
Abstract
X-linked Norrie disease, familial exudative vitreoretinopathy (FEVR), Coat's disease and retinopathy of
prematurity are severe human eye diseases and can all be caused by mutations in the Norrie disease
pseudoglioma gene. They all show vascular defects and characteristic features of retinal hypoxia. Only
Norrie disease displays additional neurological symptoms, which are sensorineural hearing loss and
mental retardation. In the present study, we analysed transcript levels of the ligand Norrin (Ndph) and its
two receptors Frizzled-4 (Fzd4) and LDL-related protein receptor 5 (Lrp5) in six different brain regions
(cerebellum, cortex, hippocampus, olfactory bulb, pituitary and brain stem) of 6- to 8-month-old
wild-type and Ndph knockout mice by quantitative real-time PCR. No effect of the Ndph knockout
allele on Fzd4 or Lrp5 receptor expression was found. Furthermore, no alterations of the transcript
levels of three hypoxia-regulated angiogenic factors (Vegfa, Itgrb3 and Tie1) were observed in the
absence of Norrin. Interestingly, we identified significant differences in Ndph, Fzd4 and Lrp5 transcript
levels in brain regions of wild-type mice and observed highest expression of Norrin and frizzled-4 in
cerebellum. Transcript analyses were correlated with morphological data obtained from cerebellum and
immunohistochemical studies of blood vessels in different brain regions. Vessel density was reduced in
the cerebellum of Ndph knockout mice but the number of Purkinje and granular cells was not altered.
This provides the first description of a brain phenotype in Ndph knockout mice, which will help to
elucidate the role of Norrin in the brain.
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Abstract  
X-linked Norrie disease, familial exudative vitreoretinopathy (FEVR), Coat’s disease and 
retinopathy of prematurity are severe human eye diseases and can all be caused by mutations 
in the Norrie disease pseudoglioma gene. They all show vascular defects and characteristic 
features of retinal hypoxia. Only Norrie disease displays additional neurological symptoms, 
which are sensorineural hearing loss and mental retardation. In this study, we analyzed the 
transcript levels of the ligand Norrin (Ndph) and its two receptors Frizzled-4 (Fzd4) and LDL-
related protein receptor 5 (Lrp5) in six different brain regions (cerebellum, cortex, 
hippocampus, olfactory bulb, pituitary and brain stem) of six- to eight-month-old wild type 
and Ndph knockout mice by quantitative RT-PCR. No effect of the Ndph knockout allele on 
Fzd4 or Lrp5 receptor expression was found. Furthermore, no alterations of the transcript 
levels of three hypoxia-regulated angiogenic factors (Vegfa, Itgrb3 and Tie1) were observed 
in the absence of Norrin. Interestingly, we identified significant differences in Ndph, Fzd4 and 
Lrp5 transcript levels in brain regions of wild type mice and observed highest expression of 
Norrin and frizzled-4 in cerebellum. The transcript analyses were correlated with 
morphological data obtained from cerebellum and immunohistochemical studies of blood 
vessels in different brain regions. Vessel density was reduced in the cerebellum of Ndph 
knockout mice but the number of Purkinje and granular cells was not altered. This provides 
the first description of a brain phenotype in Ndph knockout mice, which will help to elucidate 
the role of Norrin in the brain. 
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Introduction  
Mutations in the Norrie disease pseudoglioma gene (NDP) cause a variety of human eye 
diseases including Norrie disease, X-linked familial exudative vitreoretinopathy (FEVR), 
Coat’s disease and severe retinopathy of prematurity (ROP) (Berger et al 92a;Berger et al 
92b;Chen et al 92;Shastry et al 97b;Shastry et al 97a;Black et al 99). Among these, only 
Norrie disease can be accompanied by progressive hearing loss and mental retardation (for 
review see (Berger 98), but all four diseases exhibit similar vascular defects in the eye. Thus it 
was suggested that Norrin, the protein encoded by the NDP gene, has a role in ocular vascular 
development. This was supported by data from the respective mouse model (Berger et al 96), 
which showed malformation of the retinal and hyaloid vasculature and abnormal vessels in 
the inner ear (Richter et al 98;Ohlmann et al 04;Rehm et al 02). Further examination of retinal 
vascular development revealed that Norrin plays a role in sprouting angiogenesis. Its absence 
causes the lack of deep retinal capillary networks and subsequent retinal hypoxia which is 
accompanied by a three- to fivefold increase of expression of the angiogenic factors Vegfa, 
Itgb3 and Tie1. Retinal hypoxia seems to be one major pathogenic mechanism in the eye and 
might explain the clinical similarities in patients with all four diseases (Luhmann et al 05). 
Identification of FEVR causing mutations in the Wnt receptor Frizzled-4 (FZD4) and its co-
receptor LDL related protein 5 (LRP5) (Robitaille et al 02;Toomes et al 04), together with 
high phenotypic similarities of Ndph and Fzd4 knockout mice in eye and ear (Berger et al 
96;Richter et al 98;Rehm et al 02;Wang et al 01;Xu et al 04) led to the finding that Norrin is a 
high affinity ligand of Fzd-4 and Lrp5 and activates the canonical Wnt-/beta-catenin 
signalling pathway (Xu et al 04). Furthermore, these studies suggested that defects in this 
signalling pathway are also responsible for the progressive hearing loss observed in both, 
mice and Norrie disease patients from early adulthood onwards (Berger et al 96;Wang et al 
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01;Halpin et al 05;Rehm et al 02;Richter et al 98). Findings in the brain of homozygous Fzd4 
knockout mice indicated the requirement of the Wnt-receptor Fzd4 for normal neuronal 
development. Abnormal gait and progressive cerebellar ataxia with a dramatic loss of 
cerebellar granular cells and a progressive Purkinje cell loss have been found in this mouse 
line (Wang et al 01). At 6 month of age, these  mice also showed sparse, enlarged and 
irregular blood vessels in the cerebellum (Xu et al 04), suggesting an additional role of Fzd4 
signalling for the brain vasculature. Here, we aim to complement the understanding of 
Norrin’s role as a ligand of the Fzd4/Lrp5 receptor pair in the adult brain, and to 
identify potential pathogenic mechanisms for the mental retardation phenotype 
observed in Norrie disease patients. We therefore investigated the correlations between 
Norrin and its receptors by quantitative RT-PCR in different brain regions and explored 
whether degenerative and vascular defects as described for Fzd4 knockout mice and 
subsequent hypoxia occur in the adult brain of Ndph knockout mice. We found that Norrin 
and its receptors were widely distributed in the brain and observed differences in their 
expression levels between brain regions. Highest levels for Norrin and Frizzled-4 were 
detected in the cerebellum where we also found a slight reduction in vessel density in 
Ndph knockout mice.  We discuss a possible role of Norrin in maintenance of cerebellar 
blood vessels during adulthood.  
 
 
 
 
 
 
5 
 
Material and methods 
Animals 
The Ndph knockout mouse line and genotyping has been described previously (Berger et al 
96). Male animals were obtained by breeding of heterozygous female mice with C57Bl/6 
male mice. Whenever possible, siblings from the same litter were used for experimental 
procedures. The research was performed in accordance with the ARVO Statement for the Use 
of Animals in Ophthalmic and Vision Research. 
 
Tissue preparation, fixation, histology and immunohistochemistry 
Total brain or brain regions (olfactory bulb, cortex, cerebellum, brain stem, hippocampus, and 
pituitary) were dissected from male Ndph knockout mice and wild type littermates at the age 
of 6-8 months. For RNA isolation, tissue preparations were performed on ice and immediately 
frozen in liquid nitrogen. For immunohistochemistry the brain was embedded into O.C.T. 
compound (Tissue-Tek/ Sakura Finetek, Zoeterwoude, Netherlands) and frozen on dry ice. 
The brains were sagittally sectioned (8 µm), transferred to SuperFrost slides (Roth, Reinach, 
Germany) and dried over night at room temperature for fixation. The brain sections were 
stained with a primary antibody against Collagen type IV (polyclonal Col IV antibody, rabbit 
anti-mouse (1:250), no.2150-1470, AbD Serotec/MorphoSys, Oxford, UK) and a secondary 
Cy-3-labeled anti rabbit antibody (1:200, no 111-165-003; Dianova, Hamburg, Germany).      
For histological examination the tissue was transferred to Serra’s fixative (60% ethanol, 
11.1% (30% of 37%) formaldehyde, 10% acetic acid) and fixed over night at 4°C. 
Subsequently, the tissue was dehydrated in 70% and 100% isopropanol, embedded in paraffin, 
sectioned (7 µm), and transferred onto SuperFrost Plus slides (Roth, Reinach, Germany). 
Histological staining was performed by hematoxylin-eosin staining procedure (Mayer's 
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hemalum solution, Merck, Darmstadt, Germany). The slides were mounted with Rotihistokitt 
(Roth, Reinach, Germany) and observed under bright light illumination using a Zeiss 
Axioplan 2 microscope. Image collection was performed by using an AxioCam HRc digital 
camera (Carl Zeiss AG, Jena, Germany). 
 
Quantitative examination of hematoxylin-eosin - or ColIV-stained sections 
To quantify the cell number in the cerebellum, hematoxylin-eosin stained sagittal brain 
sections of five wild type (wt: n=5) and five Ndph knockout mice (Ndph-ko: n=5) were used. 
Within an individual cerebellum two groups of three images each were taken from two 
different sectioning planes differing by at least 140 µm. The three images within a group were 
taken from the same sagittal section at defined positions. For quantitative analysis of cell 
numbers, all Purkinje cells per image were counted and granular cells were determined in two 
areas of 250 µm2. A mean value per image was calculated. Based on the mean values for both 
cell types in each animal, the mean cell number of Purkinje cells and the mean cell density for 
granular cells in the cerebellum were calculated.  
Col IV stains the extracellular matrix of endothelial cells and was used to label blood vessels 
in the brain. Col IV stained cryosections (wt: n=6; Ndph-ko: n=6) were used to determine the 
vessel density in three different brain regions (cerebellum, cortex and hippocampus). The 
number of vessels was counted and normalized to the total area used for counting. Vessel 
density is given in number of blood vessels per 500 µm2 for each brain region. 
 
RNA isolation, DNaseI treatment and quantitative RT-PCR (Real–Time –PCR) 
Total RNA was isolated from dissected brain regions from animals of both genotypes 
(wt: n=6; Ndph-ko: n=6) using RNA extraction kits (RNeasy Mini kit: olfactory bulb, 
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pituitary; RNeasy Midi kit: cerebellum, cortex, hippocampus, brain stem; Qiagen, Hilden, 
Germany). The RNA was treated with RQ1 RNAse-Free DNase I (Promega, Mannheim, 
Germany) before concentration and integrity were checked on an Agilent Bioanalyzer 2100 
(Agilent technologies, Basel, Switzerland). DNaseI-treated RNA (0,5 - 1 µg) was reverse 
transcribed using SuperScript III RNase H– Reverse Transcriptase (Invitrogen, Basel, 
Switzerland) and random Hexamer Primers pd(N)6 (Amersham Bioscience, Freiburg, 
Germany). Quantitative real-time-PCR in 384-well plate format was performed using a 
robotic aid for pipetting and the ABI PRISM 7900 Sequence Detection System with the 
published MGB-TaqMan probes for Ndph, Fzd4, Lrp5, Itgb3, Tie1 and Vegfa (Luhmann et al 
05). Five replicates for target genes and three replicates for the internal standard 18S rRNA 
(TaqMan Ribosomal RNA Control Reagent, ABI, Rotkreuz, Switzerland) were included for 
each sample. The ∆Ct-method for relative quantification was used and data was normalized to 
the Norrin expression level in one individual wild type cortex. Data analysis was performed 
using the ABI Prism 7900HT SDS2.2 Software and a spreadsheet program. Based on the 
mean relative expression values for the technical replicates in each brain region, mean values 
for wild type and knockout groups were calculated and are shown with standard deviation 
(S.D.) error bars in the graphs. Since the technical reproducibility of the qRT results was 
very high, S.D. error bars reflect the inter-individual variability. 
 
Statistical analysis 
For statistical analysis the software package SPSS 14.0 for Windows (SPSS inc., Chicago, 
USA) was used. Real-time expression data were statistically analyzed by using ANOVA for 
repeated measurements treating brain regions as repeated measurements (dependent within 
subject factor) and defining the two groups of wt and Ndph-ko animals as independent 
between subject factors. For this test we used the ∆∆Ct values for statistical analysis, as they 
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are assumed to be normally distributed (Love et al 06). Subsequently, pair wise comparisons 
were used to identify groups with significant differences. For within subject data (brain 
regions), the parametric paired T-test or the non parametric Wilcoxon signed rank test was 
used, while for independent groups (wt versus Ndph knockout) either the parametric Student’s 
T-test or the non parametric Mann Whitney U-test was applied. 
As the ANOVA for repeated measurement analyses did not show significant differences 
between wild type and knockout animals for Fzd4, Lrp5, Itgrb3, Tie1 and Vegfa expression in 
all brain regions (see results), the statistical analysis for the pair wise comparison of 
expression levels between different brain regions were based on pooled data sets from 6 wild 
type and 6 knockout animals (total n=12).  
 
Results  
Expression studies for Ndph, Lrp5 and Fzd4 revealed differences in various brain 
regions 
We evaluated the relative expression levels of Ndph, Frizzled-4 (Fzd4) and LDL related 
protein 5 (Lrp5) in different brain regions by quantitative RT-PCR (figure 1 and table 1). 
When comparing the expression of all three genes in wild type and Ndph knockout animals, 
no significant differences were found, except the expected absence of the Ndph transcript in 
knockout animals (repeated measurement ANOVA (wt: n=6; Ndph-ko: n=6 (Ndph: p<0.01; 
Fzd4: p=0.950; Lrp5: p=0.397). But when comparing the expression levels in brain regions, 
significant differences were indicated for all three transcripts (Ndph (n=6), Fzd4 and Lrp5 
(n=12): p<0.01; figure 1, table 1). To identify the differences in transcript levels in individual 
brain regions, both the parametric paired T-test analysis of the ∆∆Ct values and the non 
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parametric Wilcoxon signed rank test analysis of the relative expression values (RQ) were 
used for pair wise comparison.  For both tests significance was set to p<0.05. 
For Ndph, we observed the highest relative expression in the cerebellum (figure 1). It was 
significantly higher than in olfactory bulb and brain stem. The latter two were not 
significantly different from each other, but were higher than those in cortex and hippocampus. 
In pituitary, only traces of Ndph expression have been detected (figure 1, table 1).  
For Fzd4 the highest level of expression was also found in cerebellum, which was 
significantly higher compared to all other brain regions (n=12, paired T-test analysis of the 
∆∆Ct values: p<0.05) figure1). In contrast to Ndph, Fzd4 showed its lowest relative 
expression level in olfactory bulb (n=12, paired T-test and Wilcoxon signed rank test: 
p<0.05). Other brain regions (cortex, hippocampus, pituitary and brain stem) showed 
intermediate transcript levels, which were statistically not distinguishable from each other 
(figure1, table 1). 
Interestingly, pituitary was the only brain region where both receptors (Fzd4 and Lrp5) were 
expressed, whereas their ligand (Norrin) was virtually absent. This might suggest a Norrin-
independent role of Fzd4 in the pituitary. 
For Lrp5, the lowest amount of transcript was found in cortex and the highest in pituitary 
(table 1). Among the other regions, the expression level in cerebellum was significantly 
higher than that in hippocampus (n=12; paired T-test and Wilcoxon signed rank tests p<0.05). 
Lrp5 in comparison to Fzd4 showed an about 8-9 fold lower expression in cerebellum, cortex 
and hippocampus, while in olfactory bulb, pituitary and brain stem the reduction was only 4-5 
fold (table 1). This indicates that different brain regions express different Fzd4/Lrp5 receptor 
transcript ratios. Our data also suggested variable receptor/ligand ratios in different brain 
regions and revealed overlapping expression of Ndph with its two receptors Lrp5 and Fzd4 in 
all but one brain region. 
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Evaluation of hypoxia regulated angiogenic factors in brain regions of Ndph knockout 
mice  
To assess potential hypoxic changes in the brain of Ndph knockout mice at the molecular 
level, we quantified the transcript levels of the three angiogenic factors integrin beta 3 
(Itgb3), tyrosine kinase receptor 1 (Tie1) and vascular endothelial growth-factor A (Vegfa) in 
the six brain regions by quantitative RT-PCR (figure 2A-C; table 2). We chose these three 
factors as they are known to be transcriptionally up-regulated by hypoxia in Norrie 
disease mouse retinae (Luhmann et al 05). Comparison of wild type (n=6) and Ndph 
knockout mice (n=6) revealed no significant differences for the three angiogenic genes 
(ANOVA for repeated measurement analysis; Itgb3, p=0.764; Tie1, p=0.620; Vegfa, 
p=0.868). Thus, we found no indication for hypoxia in Ndph knockout brains.  
Nevertheless, when we analyzed transcript levels in different brain regions by using pair wise 
comparison on pooled data sets of wildtype and knockout data (n=12), a significant difference 
was found (ANOVA for repeated measurement; p<0.01).  
Itgb3 was highest expressed in cortex and brain stem, while pituitary, olfactory bulb, 
hippocampus and cerebellum showed significantly lower levels (figure 2A, table 2; 
p<0.05 for paired T-Test and Wilcoxon signed rank test). In contrast, Tie1 mRNA 
showed highest amounts in pituitary and brain stem (figure 2B).  
The highest Vegfa expression level was found in the cerebellum, with successively 
decreasing levels in olfactory bulb, cortex, hippocampus, and pituitary (differences were 
significant in both, the Wilcoxon signed rank test and the paired T-test p<0.05 (figure 
2C). While Vegfa expression in brain stem and olfactory bulb was at comparable levels, 
variability was less in the latter region. We note, that Vegfa and Norrin display a similar ratio 
of expression levels (approximately 5:1) in the various brain regions with the exception of 
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pituitary.  In this brain region Norrin expression was virtually absent, while Vegfa was 
found at considerable levels (figure 1 and 2C).  
Taken together, our quantitative transcript analyses of angiogenic factors did not 
indicate hypoxia-induced transcriptional upregulation in Ndph knockout mice.  
 
Analysis of cerebellar morphology in Ndph knockout mice 
Because we observed highest Ndph and Fzd4 expression in cerebellum we then examined the 
morphology of this brain region in 6–8-month-old wild type and Ndph knockout mice using 
hematoxylin-eosin stained sagittal sections (figure 3). Since no gross morphological changes 
were observed in Ndph knockout mice (figures 3A, 3B), we determined the number of 
cerebellar Purkinje and granular cells from five individual animals per genotype as an 
indicator for degenerative processes. Representative high-magnification images from wild 
type and knockout sections are shown in figures 3C and D. No alterations were detected in 
the amount of Purkinje and granular cells (Mann Whitney U, p=0.138, p=0.249, respectively) 
(figure 3E).  
 
Characterization of the vasculature in cerebellum, hippocampus and cortex of wild type 
and Ndph knockout mice 
To assess potential vascular changes in the brain of Ndph knockout mice, we applied 
immunohistochemistry. We stained for Collagen IV in sagittal sections of whole brains as a 
marker for the extracellular matrix of vascular endothelial cells (figure 4A). No obvious 
differences in vessel size and morphology were noted in hippocampus, cortex and the 
cerebellum (Figure 4B). However, the distribution of blood vessels in the cerebellum of Ndph 
knockout mice occasionally seemed to be less dense compared to that in the wild type. 
Therefore, vessels in all three brain regions from wild type and Ndph knockout animals (n=6) 
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were counted and displayed as mean vessel density (figure 5A). We found a significant 
reduction of 16.4 % in the cerebellum, while an effect of the Ndph knockout on the vessel 
density in hippocampus and cortex was not detected (figure 5A, ANOVA for repeated 
measurement (p<0.05) and 2-tailed independent sample T-test (p< 0.05)).  
In addition, we found for both genotypes that the vessel density of the cerebellum was 
significantly higher than in cortex and hippocampus (figure 5A; ANOVA (p<0.01); paired T-
test and Wilcoxon signed rank test; n = 6; p<0.05). 
 We attempted to localize the statistically significant reduction in the cerebellar vessel 
density to the layers of molecular, granular/Purkinje cell or white matter. We found that 
vessel density in the white matter layer (69.8% ± 16.3 % of Wt) was significantly 
reduced (2-tailed independent sample T-test (p = 0.034) (figure 5B). In contrast, the 
trend of reduction in vessel densities of the molecular layer (86.0% ± 15.9 % of Wt) and 
the granular/Purkinje cell layer (86.8 % ± 22.8% of Wt) was not statistically significant 
(Figure 5B).  
Taken together, our data suggested that the Ndph knockout had no general effect on the 
vascular system in the brain, but causes a mild reduction in vessel density in the white matter 
of the cerebellum. 
Discussion  
The data reported here expand our knowledge about the quantitative mRNA expression of 
Norrin and its two receptors Frizzled-4 and LDL related protein 5 in different brain regions of 
adult mice. Former studies located Ndph transcripts to retina and total brain. RNA in situ 
studies (Berger et al 96) showed, in good accordance with our quantitative data, signals in the 
olfactory bulb and in Purkinje cells of the cerebellum, where we found highest Norrin 
transcript levels. Our data now provide additional evidence that Norrin is more widely 
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expressed in brain including now also cortex, hippocampus and brain stem, while in pituitary 
only traces of Norrin were detected. Similarly, significant expression differences between the 
brain regions were found for Fzd4 and Lrp5 and, like Ndph, the highest expression of Fzd4 
was detected in cerebellum. Fzd4 and Lrp5 were co-expressed in all brain regions in which 
Ndph was present. In combination with the observation that Norrin activates the Wnt-/beta-
catenin signalling pathway via FZD4 and LRP5 in cell culture assays (Xu et al.04), our 
expression data are consistent with the potential modulatory role of Norrin for the Wnt 
signalling pathway via FZD4 and its co-receptor LRP5 in the brain.  
The expression patterns further suggest Norrin-independent functions of FZD4 and LRP5 in 
the pituitary and raise the possibility of a regulation of Wnt-signalling by changes in the 
expression levels of the ligand Norrin across different brain regions.   As indicated by our 
results, a regulation of this signalling may also occur by changes in the ratio of FZD4 to 
LRP5 levels in different brain regions, which we either found to be 8-9 in cerebellum, 
cortex and hippocampus or 4-5 in olfactory bulb, pituitary and brain stem. 
Based on the similarity in expression patterns of Norrin and VEGFA across different 
brain regions, we hypothesize that concerted action of both factors may play a role in 
controlling brain angiogenesis. While the role of VEGFA and its signalling for this 
process is well established also in the cerebellum (Acker et al 01;Zachary and Gliki 01), 
the knowledge about Norrins role in angiogenesis is limited (Luhmann et al 05;Berger et 
al 96;Richter et al 98). Whether an interaction between Norrin and VEGFA signalling 
exists, requires further investigations.  
Homozygous Fzd4 knockout mice show vascular defects in the retina, progressive hearing 
loss, growth retardation, abnormal gait and premature death (Xu et al 04;Wang et al 01). It 
was shown that these mice exhibit cerebellar degeneration, starting with a massive loss of 
granular cells between postnatal days p14 and p19 and a later reduction of Purkinje cells 
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(Wang et al 01). In contrast to this mouse model, we detected no numerical reduction of 
these cells in the cerebellum of six- to eight-month-old Ndph knockout mice. This suggests 
that no degenerative changes leading to permanent cell loss are present up to this age 
although we can not exclude any transient changes during earlier development or age-
related manifestations (figure 3). We conclude that Norrin, despite its high expression in the 
cerebellum (figure 1), does not have a crucial role for the maintenance of neuronal cells, in 
particular the granular and Purkinje cells. This striking difference between Ndph and Fzd4 
knockout mouse lines suggests that Fzd4 requires additional ligands other than Norrin. Most 
likely these ligands are members of the Wnt family, the conventional ligands for Frizzled 
receptors, which are widely and commonly expressed in the brain and play important roles in 
neuronal development and synapse formation as well as in control of neuronal apoptosis and 
neurotrophin expression (Ciani and Salinas 05;Patapoutian and Reichardt 00).  
However, we cannot exclude a direct effect of Norrin on neurons in different brain regions. 
During retinal development, the ectopic over-expression of Norrin in the lens led to an 
increased number in retinal progenitor cells in vivo and suggested a pro-proliferative effect on 
neuronal precursors of Norrin (Ohlmann et al 05). While we did not observe any indications 
for such a role in the adult brain, it remains to be elucidated, whether a similar Norrin 
function might be important during the development of the brain.  
In addition to the neuronal degeneration of granular and Purkinje cells, progressive vascular 
enlargement and vascular disorganizations were described in the cerebellum of six-month-old 
homozygous Fzd4 knockout mice. This vascular appearance was described as sparse, enlarged 
and irregular (Xu et al 04). While our examination of the hippocampal, cortical and 
cerebellar vasculature of Ndph knockout mice at comparable age, using comparable methods, 
did not show obvious differences in vascular morphology and size even at higher 
magnifications. the significant 16% reduction in vessel density in the cerebellum of Ndph 
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knockout mice suggests a sparser vessel distribution.  Furthermore, our data from the 
different cerebellar layers shows a general trend of reduced vessel density in all three 
layers, which reached significance in the white matter.  
This mild reduction in vessel density might indicate a potential role of Norrin for the 
maintenance of the vasculature in the cerebellum and revealed the first phenotypic 
alterations in brain of Ndph knockout mice. Supportively, Ndph and Fzd4 expression 
was highest in this brain region.   
Norrin’s role for the vascular system in brain appears only modulatory, while it is essential in 
the retina.  Thus, it seems that the function of Norrin for the vasculature shows a tissue-
specific effect. Tissue-specificity has been reported in eye and ear of Ndph knockout 
mice (Luhmann et al 05;Rehm et al 02). While the progressive hearing loss in Norrie 
disease patients and in Ndph knockout mice begins during early adulthood,  the severe 
phenotype in the eye is already present shortly after birth (Rehm et al 02;Halpin et al 
05;Warburg 66;Luhmann et al 05). Furthermore, the degeneration of the capillary 
network in the stria vascularis starts shortly after normal development suggesting a 
maintenance role for Norrin in the ear (Rehm et al 02). In contrast, development rather 
than maintenance is affected in the retina (Luhmann et al 05).  
Hypoxic pathogenic processes as seen in Ndph knockout retinae were not indicated in the 
brain, since we did not find up-regulation of integrin beta 3, Vegfa and Tie1. We chose these 
markers since they are significantly higher expressed in retinae of Ndph knockout mice under 
hypoxic conditions (Luhmann et al 05). In addition, Vegfa is upregulated by hypoxia in brain 
(Marti and Risau 98;Ozaki et al 99).  Since we did not find differences between wildtype 
and knockout animals for these three markers in the cerebellum, we conclude that the 
mild reduction in vessel density in Ndph knockout mice does not lead to a severe oxygen 
deficiency. Therefore, functional consequences of the reduced vessel density in the 
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cerebellum remain uncertain at the molecular level. Future experiments will address Norrin’s 
role in hypoxia-induced angiogenic responses and ischemic conditions in the brain.  
This study provides initial evidence for a mild vascular defect in the brain of Ndph knockout 
mice. The brain can also be affected in patients with Norrie disease (Warburg 66) but the 
underlying processes are poorly characterized. The phenotypic features described in the brain 
vary and, consequently, it is difficult to understand the action of Norrin in the brain. The 
phenotype has often been described in general terms, such as “mental retardation”. For 
example, in a large Cuban kindred with 46 affected members, 45% of the examined patients 
were described to show moderate or severe mental retardation (Fuchs et al 94). In other 
families severe developmental delay has been described, with some patients showing 
hypotonia or epileptic seizures (Schuback et al 95;Yamada et al 01;Lev et al 04;Fuentes et al 
93). The observations suggest that these clinical symptoms can occur in Norrie disease and 
probably reflect a pleiotropic function of Norrin also in the brain. It is tempting to speculate 
that mild vascular changes, as observed in the Ndph knockout mouse model, might also occur 
in Norrie disease patients and lead to a higher susceptibility to seizures. This idea is supported 
by the findings that, in a rodent model, hypoxia has been shown to be epileptogenic in 
immature animals, but not in adults (Jensen et al 91). Therefore, the concept that absence of 
Norrin leads to vascular defects and to hypoxic insults in respective organs could be 
applicable not only to retina but also to the brain, although we cannot exclude the possibility 
that the function of Norrin may differ between mice and human. 
Therefore, further clinical examinations in patients with Norrie disease, FEVR, ROP and 
Coat’s disease, especially addressing extra ocular vessel manifestations, could help to clarify 
the role of the Norrin/Frizzled-4/Lrp5 signalling for vascular development or maintenance of 
vasculature in different tissues. To the best of our knowledge, e.g. FEVR patients show no 
clinical symptoms in brain or ear, which is in contrast to Norrie disease patients and to 
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findings in the Fzd4-deficient mice (Xu et al 04). To further characterize these differences in 
phenotype between mouse and human and to understand pathogenic mechanisms, a more 
thorough examination especially in the cerebellum might be worth considering.   
Although our study only showed a mild effect of the Ndph knockout on the vasculature in 
cerebellum, it might be worthwhile to examine different brain regions of patients for 
pathogenic changes.  Vascular alterations might potentially help to explain the phenotypic 
variability of mental retardation seen in Norrie disease patients (Fuchs et al 94).  In this 
context it is interesting to note that the cerebellum has been shown not only to be involved in 
motor function but also in certain aspects of cognition and affective functioning, including 
emotional reactivity and mood (Gordon 07). It was documented that patients with isolated 
cerebellar hypoplasia (incomplete or underdevelopment of the cerebellum) were predisposed 
to psychomotor delays and cognitive impairments, occasionally  including epileptic seizures 
(Ventura et al 06). Furthermore, patients with cerebellar lesions in the posterior inferior artery 
showed deficits in mainly visual-spatial working and episodic memory as well as emotional 
withdrawal (Exner et al 04). This might suggest that any potential defect in the Norrin-Fzd4-
Lrp5 signaling pathway affecting the cerebellum could possibly contribute to the mental 
retardation phenotype in Norrie disease patients.  
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Table 1 Relative Expression ± standard deviation (S.D.) of Norrin (Ndph) and its two 
receptors Frizzled-4 (Fzd4) and LDL related protein 5 (Lrp5) in different brain regions of 
wild type and Ndph knockout mice. The data was normalized to Norrin expression in the 
cortex of an individual animal. 
 
Gene Brain region Relative Expression ± S.D. 
  Wt Ndph ko 
Ndph Cerebellum 3.06 ± 0.81 0.00 ± 0.00 
 Cortex 1.22 ± 0.39 0.00 ± 0.00 
 Hippocampus 0.97 ± 0.47 0.00 ± 0.00 
 Olfactory bulb 2.19 ± 0.41 0.00 ± 0.00 
 Pituitary 0.03 ± 0.02 0.01 ± 0.01 
 Brain stem 1.85 ± 1.23 0.00 ± 0.00 
    
Fzd4 Cerebellum 5.07 ± 1.32 4.53 ± 1.10 
 Cortex 2.83 ± 0.75 3.00 ± 1.18 
 Hippocampus 4.42 ± 2.47 3.33 ± 0.88 
 Olfactory bulb 1.77 ± 0.38 2.13 ± 0.49 
 Pituitary 3.45 ± 1.47 3.27 ± 0.72 
 Brain stem 3.67 ± 2.14 3.61 ± 1.51 
    
Lrp5 Cerebellum 0.59 ± 0.33 0.47 ± 0.30 
 Cortex 0.33 ± 0.21 0.27 ± 0.14 
 Hippocampus 0.48 ± 0.29 0.30 ± 0.11 
 Olfactory bulb 0.45 ± 0.10 0.42 ± 0.16 
 Pituitary 0.83 ± 0.27 0.64 ± 0.36 
 Brain stem 0.64 ± 0.51 0.49 ± 0.20 
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Table 2 Relative Expression ± standard deviation (S.D.) of the angiogenic factors integrin 
beta 3 (Itgrb3), tyrosine kinase receptor 1 (Tie1) and vascular endothelial growth factor A 
(Vegfa) in different brain regions of wild type and Ndph knockout mice. The data was 
normalized to Norrin expression in the cortex of an individual animal. 
 
Gene Brain region Relative Expression ± S.D. 
  Wt Ndph ko 
Itgb3 Cerebellum 0.22 ± 0.10 0.19 ± 0.06 
 Cortex 0.46 ± 0.17 0.45 ± 0.06 
 Hippocampus 0.24 ± 0.10 0.20 ± 0.03 
 Olfactory bulb 0.24 ± 0.08 0.24 ± 0.06 
 Pituitary 0.28 ± 0.09 0.26 ± 0.06 
 Brain stem 0.40 ± 0.17 0.38 ± 0.13 
    
Tie1 Cerebellum 2.96 ± 0.88 2.41 ± 0.35 
 Cortex 1.94 ± 0.45 2.41 ± 0.63 
 Hippocampus 1.73 ± 0.72 1.83 ± 0.56 
 Olfactory bulb 1.65 ± 0.54 1.88 ± 0.47 
 Pituitary 3.79 ± 1.00 3.72 ± 0.73 
 Brain stem 3.62 ± 1.72 3.95 ± 1.76 
    
Vegfa Cerebellum 13.49 ± 3.53 12.70 ± 4.02 
 Cortex 6.98 ± 0.63 7.88 ± 1.23 
 Hippocampus 6.32 ± 3.01 5.92 ± 1.09 
 Olfactory bulb 9.70 ± 2.21 8.97 ± 2.16 
 Pituitary 3.46 ± 0.92 3.29 ± 1.51 
 Brain stem 9.74 ± 5.15 9.62 ± 3.51 
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Figure Legends 
Figure 1: Differential expression of Ndph, Lrp5 and Fzd4 in six brain regions of mice.  
The relative expression ± standard deviation (S.D.) of these genes was determined by 
quantitative RT-PCR in Ndph wild type and knockout mice (Wt: n=6; ko: n=6).  All relative 
expression values were normalized to an individual Ndph expression level in wild type cortex.  
 
Figure 2: Expression of three hypoxia regulated angiogenic factors. Quantitative analysis of 
transcript levels of integrin beta 3 (Itgrb3) (A), tyrosine kinase receptor 1 (Tie1) (B) and 
vascular endothelial growth-factor A (Vegfa) (C) in six brain regions. The mean relative 
expression is presented ± S.D. (wt: n=6; ko: n=6). Note the differences in the scale of the 
aches for the three transcripts. 
 
Figure 3: Gross Morphology and cell number of Purkinje and granular cells are not altered in 
Ndph knockout mice. Hematoxylin-eosin stains of sagittally sectioned cerebellum from Ndph 
wild type and knockout mice. A, C: wild type; B, D: Ndph knockout; E: Quantitative 
assessment of Purkinje and granular cell numbers in the cerebellum. Mean cell number ± S.D. 
of Purkinje cells/section and granular cells/250 µm2 (n=5). Scales in A and B = 200 µm, in C 
and D = 50 µm. 
 
Figure 4: Vessel morphology in different brain regions 
A: Collagen IV immunohistochemistry of the vasculature in cerebellum, hippocampus and 
cortex of wild type (Wt) and Ndph knockout (Ko) mice. Counter-staining was performed with 
DAPI. Representative hematoxylin-eosin stained images are shown in the left column. B: 
Higher magnification of Col IV immunohistochemistry without counterstaining to 
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visualize the vessel morphology. The white frames indicate the areas, from which images 
of higher magnification for 4 B have been taken MCL: Molecular cell layer, PCL: 
Purkinje cell layer, GCL: Granular cell layer, WM: White Matter, CA3-1: CA3-1 
region; DG: Dentate Gyrus; FC: Frontal cortex. 
 
 
Figure 5:  Quantitative assessment of vessel density in different brain regions and 
different layers of the cerebellum.  
A: Col IV stained vessel sections were evaluated in defined areas from six sections of each 
animal and brain region. The mean vessel density per 500 µm2 ± S.D. is shown in the graph. 
The asterisk indicates statistical significance for the reduction in vessel density in Ndph 
knockout mice based on parametric tests (* p<0.05, ANOVA for repeated measurements 
(between subject test: p=0.037, Student’s T-test: p=0.037). 
B: Quantitative assessment of vessel density in the molecular layer, granular/Purkinje 
cell layer and white matter  
The number of Col IV stained vessels in each layer was counted and normalized to its 
area. The mean vessel density ± S.D. per 500 µm2 for wildtype and Ndph knockout 
animals is shown. The asterisk indicates statistical significance in vessel density found in 
the white matter of Ndph knockout mice (Students T-Test p=0.034). 
 
 
 
